Imprivata Agrees to Thoma Bravo Acquisition

Imprivata, a leading provider of identity and access management solutions, has agreed to be acquired by Thoma Bravo, a private equity firm. This acquisition is a significant development for the company, marking a new chapter in its growth and expansion.

The acquisition is expected to close in the second half of 2021, pending regulatory approvals and other customary closing conditions. Thoma Bravo has a proven track record of investing in and growing successful companies like Imprivata.

The acquisition will provide Imprivata with the resources and support needed to accelerate its innovation and growth.

Intriguing read: Summit Growth Partners

Imprivata has entered into a definitive agreement to be acquired by an affiliate of Thoma Bravo, LLC, a leading private equity investment firm.

The acquisition is valued at approximately $544 million, with Thoma Bravo paying $19.25 per share, representing a 33% premium to Imprivata’s last closing stock price of $14.50.

This transaction represents a great outcome for Imprivata’s current shareholders, with Omar Hussain, President and CEO of Imprivata, expressing excitement about Thoma Bravo’s investment in the company.

Check this out: Hillhouse Investment Management Ltd

Thoma Bravo’s successful track record in both security and healthcare IT has made them a strong partner for Imprivata, with a unique opportunity to expand its market presence by providing additional high-value products to its customers.

Imprivata’s security platform provides mission-critical technologies that are deeply embedded within the daily workflows of the world’s largest and most prestigious hospitals and healthcare institutions.

The acquisition is expected to support Imprivata’s growth trajectory as a private company, with Thoma Bravo looking forward to continuing to support the company’s growth.

Worth a look: Blackstone Equity Company

The transaction valued at approximately $544 million is a significant milestone for Imprivata. This valuation is the result of a definitive agreement between Imprivata and an affiliate of Thoma Bravo, LLC.

Imprivata's shareholders will receive $19.25 in cash per share, representing a 33% premium to the company's last closing stock price of $14.50. This premium shows the confidence Thoma Bravo has in Imprivata's future prospects.

Under the terms of the agreement, Imprivata will become a private company, allowing it to pursue market opportunities without the scrutiny of public markets. This change in status will give Imprivata the freedom to innovate and expand its products and services.

The Imprivata security platform is deeply embedded within the daily workflows of the world's largest and most prestigious hospitals and healthcare institutions. This strong position in the market has caught the attention of Thoma Bravo, who sees Imprivata as a leader in healthcare IT security.

See what others are reading: Top Lower Middle Market Private Equity Firms